Clin2
NCT03503708Possibly a fitNot yet recruiting

Herbal supplement for liver function in alcoholic liver disease

Alcoholic Liver Disease

Part of Digestive system clinical trials.

This study tests whether a herbal supplement can improve liver function in people with alcoholic liver disease. If you have liver damage from alcohol but not severe cirrhosis, this supplement may help your liver recover.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You must have been drinking alcohol regularly and continued drinking until 4 weeks before starting the study.
  • Your liver enzyme blood tests (ALT and AST) must be elevated to more than 1.5 times the normal upper limit.
  • You must not have severe liver scarring (cirrhosis) or a life expectancy of less than 3 months.
  • You must not have significant kidney disease (eGFR below 60).
  • You cannot be pregnant, planning to become pregnant, or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04320199Recruiting
Fermented beetle powder for alcohol-related liver problems

This trial tests whether a fermented powder made from a specific beetle can improve or protect the liver after alcohol-related liver injury. It’s looking for people with certain liver blood test levels, and it excludes several conditions and recent herbal or liver-affecting treatments.

Pusan, Ami-dong
NCT04400604Recruiting
Study of liver disease risk from heavy alcohol use

This study looks at people with heavy alcohol use who may have alcohol-related liver damage. It aims to better understand liver disease risk and how it changes over time, using blood tests, some scans, and possibly stored tissue.

Lille
NCT06613698Recruiting· Phase 2
Testing an investigational drug for alcohol-related liver disease

This trial tests whether a new drug, GSK4532990, is safe and effective compared to a placebo in adults aged 18 to 70 with liver disease caused by alcohol use. The study aims to see if the drug can help treat advanced chronic liver disease.

Chandler, Arizona
NCT05178069Recruiting· Phase 2
Probiotic supplement study for alcohol use disorder and liver injury

This Phase 2 trial studies whether a probiotic (LGG) can improve health in people with alcohol use disorder and alcohol-related liver injury. It’s not an alcohol treatment study, so participants are mainly joining to see how the supplement affects the body and liver-related outcomes.

Louisville, Kentucky
NCT07466485Not yet recruiting· Phase 2
Tocotrienol for liver protection in alcoholic fatty liver disease

This study tests whether a natural form of vitamin E (called tocotrienol) can protect the liver in people with alcoholic fatty liver disease who have stopped drinking. It aims to see if this supplement improves liver health and reduces inflammation.

Cheras, Kuala Lumpur
NCT07428538Recruiting· Phase 3
Testing larsucosterol for severe alcohol-related hepatitis

This trial tests a new medicine called larsucosterol to see if it helps people with severe alcohol-related hepatitis (liver inflammation from heavy drinking). If you qualify, the study will monitor your safety and recovery over 90 days.

Birmingham, Alabama

Hear when a new Alcoholic Liver Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.